Ucwaningo Olusha Lokusebenzisa I-Psychedelics Ukulwa Nokugula Ngengqondo

A BAMBA MahhalaRelease 8 | eTurboNews | eTN
Isithombe sikaLinda Hohnholz
Ibhalwe ngu Linda Hohnholz

Amacala ezempilo yengqondo ayaqhubeka nokukhuphuka futhi alimaza kakhulu uhlelo lokunakekelwa kwezempilo. Ngenhlanhla, ama-psychedelics afana ne-DMT, i-psilocybin, i-MDMA, ne-LSD ayathuthukiswa ukwelapha izifo zengqondo ezihlukahlukene ezifana nokudangala, ukukhathazeka, kanye ne-PTSD. Olunye ucwaningo olwenziwa abacwaningi e-Johns Hopkins Medicine lubonisa ukuthi ukwelashwa kwengqondo nge-psilocybin kwakhulula izimpawu ze-depressive disorder enkulu okungenani unyaka kwezinye iziguli. Olunye ucwaningo oluvela kososayensi baseMcGill University lubonise ukuthi imithamo ephansi evamile ye-LSD inciphisa izimpawu zokukhathazeka ngokusebenzisa izindlela ze-neurobiological ezifana nama-antidepressants avame ukunikezwa. Imiphumela emihle iholele ekwenyukeni kwenzalo yabatshalizimali, ngoxhaso lwezinkampani zemithi yengqondo eyeqa amaRandi ayizigidi ezingama-700 ngo-2021.

I-Cybin Inc. isungule isikhundla sobuholi endaweni yokwelapha ye-psychedelic ngokusekelwe endleleni yayo yesayensi yobunikazi kanye nesimiso sokuthuthukiswa kwezidakamizwa.

Ngomhla zingama-29 kuNdasa, uCybin wamemezela ukuthi uphothule ngempumelelo izifundo ze-vivo preclinical ezihlola i-psilocybin analogue CYB003 engase ibe khona yokwelashwa okungaba khona kwe-depressive disorder (MDD). Idatha evela ocwaningweni lwe-vivo preclinical ibonisa ukuthi i-CYB003 ibekezelelwa kahle ngemva kwemithamo eminingi ezinhlotsheni eziningi. UCybin uhlela ukuhambisa i-Investigational New Drug (IND) ne-US Food and Drug Administration (FDA) engxenyeni yesibili ka-2022 kanye nokuqala ukuhlolwa komtholampilo kweSigaba 1/2a maphakathi no-2022.

“Ukuphothulwa kwalezi zifundo ze-CYB003 ze-vivo kumelela ingqopha-mlando ekuthuthukiseni lolu hlelo ekuthuthukisweni komtholampilo kokuqala komuntu futhi kusisondeza ekuqhubekeleni phambili kwe-CYB003 njengomuntu oseqophelweni eliphezulu lokwelapha isifo sengqondo nokulutheka. ,” kusho isikhulu sakwaCybin uDoug Drysdale. “Sihlela ukugxila esivivinyweni seSigaba 1/2a e-United States. Sikholelwa ukuthi lokhu kuzosivumela ukuthi sikhulise ucwaningo ngokuthuthuka komtholampilo okusesigabeni sokuqala futhi sibe uvivinyo olungase lube banzi lweSigaba 2b, kuyilapho ngesikhathi esifanayo siqoqa inani elikhulu ledatha ukusekela izifundo ezifika sekwephuzile.”

U-Cybin naye usanda kumemezela ukuthi uhlanganyele neChopra Foundation ukwandisa imfundo nokuqwashisa ngokusetshenziswa okungenzeka kwe-psychedelics ukusekela impilo nempilo yengqondo. Ucwaningo lwakamuva lubonisa ukuthi ukwelapha okusizwa yi-psychedelic kungase kuthuthukise izinga lempilo yabantu abanezifo zengqondo.

Ngokungeziwe ezinhlelweni zayo eziqhubekayo zokuthuthukiswa kwezidakamizwa, umtholampilo kanye nophenyo, uCybin uhlanganyela ngokuzibophezela kweChopra Foundation ekuqinisekiseni ukufinyeleleka kwezinsiza zempilo yabo bonke, kuhlanganise nalabo abasemiphakathini enganakiwe.

"Sihlonishwa ukubambisana neChopra Foundation, futhi ikakhulukazi, ukuba yingxenye ye-NeverAlone Initiative. Kuningi okuqondwayo ngabagula ngengqondo, njengoba sekuphele amashumi eminyaka befundelwa ezikhungweni zemfundo ephakeme, kodwa usemkhulu umsebenzi wophenyo okusamele wenziwe,” kusho isikhulu sakwaCybin uDoug Drysdale. "E-Cybin, sisebenzisa ubuchwepheshe bekhemikhali yezokwelapha kanye nokulethwa kwezidakamizwa ukuze sakhe phezu kwedatha ekhona yomtholampilo futhi sithuthukise ulwazi lwesiguli ngokunqoba imikhawulo yokwelashwa kwamanje kwesifo sengqondo."

Ngenyanga edlule, uCybin uthumele imiphumela ye-Q3 ngemali kanye nemali elingana nesamba esingu-C$63.6 wezigidi kusukela ngomhla ka-31 Disemba 2021. Izindleko zokusebenzisa ukheshi zaba C$12 wezigidi ngekota ephele ngoDisemba 31, 2021, lapho u-C$2.5 wezigidi bekungesikhathi esisodwa, okungezona. -izindleko eziqhubekayo. Izindleko okungezona ezekheshi zenze isamba esingu-C$5.2 wezigidi ngokulahleka okuphelele kwezigidi ezingu-C$17.2.

UCybin uphinde wabika ezinye izigigaba ezibalulekile, okuhlanganisa nokuphothula izifundo zangaphambi komtholampilo ezingaphezu kwe-140 ezisekela ukuthuthuka kwe-CYB003, CYB004, kanye namanye ama-molecule aphathelene ne-psychedelic maqondana namafayili okulawula, okumaka izifundo ezintsha ezingama-50+ ezaqedwa ngoJanuwari 2022 kuphela, kanye nokuthola ilungelo lobunikazi laseMelika. ye-CYB004 iqhubeka nokuqinisa iphothifoliyo yayo ye-IP.

Umphathi Omkhulu uDoug Drysdale uthe inkampani iqhubekile nokwenza inqubekelaphambili enkulu kule kota ekuthuthukiseni ama-molecule ayo asekelwe ngokwengqondo ekuthuthukisweni komtholampilo, ifinyelele ezimisweni zokulawula, iphothule izifundo eziningi zangaphambi komtholampilo kanye nokusungula amaketanga athembekile e-US nase-UK.

Mayelana umbhali

Isithombe sikaLinda Hohnholz

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...